18 September 2013
Russia’s Federal Service on Healthcare Surveillance (Roszdravnadzor) and the Ministry of Health have agreed that clinical trials conducted on medical devices prior to January 2013 can be used to support applications for the renewal of or new marketing registration for devices in the 2013-2014 timeframe.
This comes as part of the agency’s ongoing initiative to simplify the device registration procedure following consultations with industry in which concern was expressed about the existing re-registration process.
Commenting on the agency’s decision, acting Roszdravnadzor head Michael Murashko noted, "The theme of simplifying registration procedures is highly relevant today … with two main goals: to ensure the marketing of medical products with proven efficacy and safety, and to harmonize Russian legislation with that of developed countries."
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024